Coronary artery spasm induced by capecitabine

Journal of Cardiovascular Medicine
Alfonso SestitoGaetano Antonio Lanza

Abstract

Capecitabine is a new chemotherapeutic agent considered highly specific for sensitive tumour cells, which convert the drug to 5-fluorouracil. Capecitabine is administered on an ambulatory basis for the treatment of metastatic breast and colorectal cancer, and both general practitioners and specialists are likely to deal with patients treated with this drug. We describe the case of a 44-year-old woman, with no cardiovascular risk factors, who started therapy with capecitabine for relapsing of breast carcinoma. She subsequently developed effort angina. Standard electrocardiogram and echocardiography were normal, whereas ST-segment elevation and angina were induced during exercise stress test. Capecitabine was withdrawn and therapy with diltiazem and transdermal nitroglycerine was started. The patient became asymptomatic and repeated symptom-limited exercise stress test did not induce any ST-segment changes or angina, even after withdrawal of anti-ischaemic therapy, thus confirming the hypothesis of capecitabine-induced coronary artery spasm as the cause of patient's symptoms.

References

Mar 1, 1991·European Heart Journal·R J LuwaertM Beauduin
Aug 10, 1999·Drugs·M Dooley, K L Goa
Jul 4, 2001·Annals of Oncology : Official Journal of the European Society for Medical Oncology·B SchnetzlerA P Sappino
Sep 22, 2001·The American Journal of Medicine·A Maseri, G Lanza
Nov 2, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·E Van CutsemUNKNOWN Xeloda Colorectal Cancer Study Group
Jun 22, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·N FrickhofenM Sigmund

❮ Previous
Next ❯

Citations

Oct 1, 2009·Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·C CamaroH A Bosker
Sep 1, 2006·Photomedicine and Laser Surgery
Jan 27, 2007·Cardiovascular Ultrasound·Maurizio GalderisiOreste de Divitiis
Nov 28, 2013·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Thomas KlagAnastasios Athanasiadis
Sep 4, 2012·The American Journal of Cardiology·Andrew P AmbrosyRonald M Witteles
Feb 20, 2010·Farmacia hospitalaria : órgano oficial de expresión científica de la Sociedad Española de Farmacia Hospitalaria·F Becerril MorenoL Arteche Eguizabal
May 21, 2008·Journal of Electrocardiology·Roy BeinartPierre Chouraqui
Jun 13, 2009·Journal of the American College of Cardiology·Edward T H Yeh, Courtney L Bickford
Jul 9, 2016·International Journal of Cardiology·Luisa De GennaroPasquale Caldarola
Mar 30, 2016·Circulation·Joerg HerrmannKonstantinos Marmagkiolis
Oct 19, 2011·Circulation·Gaetano Antonio LanzaFilippo Crea
Jun 30, 2009·Journal of Cardiovascular Medicine·Jaya D Bathina, Syed Wamique Yusuf

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Carcinoma, Ductal

Ductal carcinoma is a malignant neoplasm involving the ductal systems of any of a number of organs, such as the mammary glands, pancreas, prostate or lacrimal gland. Discover the latest research on ductal carcinoma here.

Related Papers

Emergency Medicine Journal : EMJ
C A Papadopoulos, H Wilson
Annals of Oncology : Official Journal of the European Society for Medical Oncology
N FrickhofenM Sigmund
The Canadian Journal of Cardiology
Daniela CardinaleNicola Colombo
Clinical Journal of Oncology Nursing
Marybeth Singer
© 2022 Meta ULC. All rights reserved